


Genelex
Biotechnology Research • Seattle, Washington, United States • 21-50 Employees
Company overview
| Headquarters | 3101 Western Ave, Suite 100, Seattle, Washington 98121, US |
| Phone number | +18008378362 |
| Website | |
| SIC | 807 |
| Keywords | Pharmaceuticals, Clinical Trials, PGx, Polypharmacy, Pharmacogenetics, Cytochrome P450, Drug Sensitivity Testing, Precision Prescribing |
| Founded | 1987 |
| Employees | 21-50 |
| Socials |
Key Contact at Genelex
Jessica Oesterheld
Medical Director
Genelex Email Formats
Genelex uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 45.6% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 22.3% |
{first name}@company.com | john@company.com | 15.1% |
{first name}{last name}@company.com | johndoe@company.com | 9.8% |
{first name}_{last name}@company.com | john_doe@company.com | 7.2% |
About Genelex
Founded in 1987, Genelex is a highly accredited leader in precision medication management and one of the first clinical laboratories to provide pharmacogenetic testing and interpretation as creator of YouScript - a patented, proprietary and powerful clinical decision support tool. Genelex pharmacogenetic tests reveal natural variations that determine how the body processes commonly prescribed medications. More than 90% of the population have genetic variations that determine how their bodies process drugs. This applies to both prescription and over-the-counter medications. Due to these genetic differences, two people can take the same dose of the same drug but respond in very different ways. Each year in the United States, 8.6 million dangerous adverse drug events occur, resulting in more than 100,000 deaths. The FDA estimates the cost at a minimum of $30 billion per year. Our expert staff and state-of-the-art laboratory are focused and driven to prevent drug-gene and drug-drug interactions, especially in patients with significant polypharmacy who are at most risk. Genelex is one of the longest-running leaders pharmacogenetics. We work diligently to help polypharmacy patients and physicians improve medication outcomes with pharmacogenetic testing and offer both clinical and research level PGx testing to CRO's and pharmaceutical companies helping to ensure safer drugs to market. We look forward daily to our role in making pharmacogenetics a commonplace term in every physician's office and kitchen table across the United States.
Genelex revenue & valuation
| Annual revenue | $14,000,000 |
| Revenue per employee | $584,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $44,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Genelex has 7 employees across 3 departments.
Departments
Number of employees
Funding Data
Genelex has never raised funding before.
Genelex Tech Stack
Discover the technologies and tools that power Genelex's digital infrastructure, from frameworks to analytics platforms.
PaaS
Security
Frequently asked questions
4.8
40,000 users



